View Author
scopus: 6603575978

Dulk, H. den

(Hans den Dulk)


cisplatin yeast resistance npr 2⌬ cells strain sensitivity cerevisiae npr 2 srpk 1 doxorubicin sky 1 disruption cisplatin resistance cancer 2780 cells protein expression sky 1 gene schenk concentration npr 2 gene assay drug resistance cisplatin sensitivity agent experiment isogenic saccharomyces cerevisiae anticancer saccharomyce medium sequence as-srpk transposon phenotype doxorubicin resistance mutation kinase sky 1p srpk 1 protein repair cisplatin sensitivity profiles 30° c vector mgsc-sky 1 cells as-srpk 1 study survival netherland cisplatin-resistant tumor mechanism cisplatin sensitivity gene treatment sky 1⌬ cells rousselet mgsc-sky cadmium chloride doxorubicin accumulation spot assays yeast cells accumulation antisense anticancer agents npr 2⌬ strain anticancer drug resistance stoter g plate cytotoxicity protein-specific burger nitrogen doxorubicin sensitivity yeast strains antisense odns cadmium product pyctef npr 2p mutator phenotype




2 Most Recent Publications

Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill. (Article)
Schenk, P.W. Brok, M. Boersma, A.W.M. Brandsma, J.A. Dulk, H. den Burger, H. Stoter, G. Brouwer, J. Nooter, K.
2003-08-01
SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line (Article)
Schenk, P.W. Boersma, A.W.M. Brandsma, J.A. Dulk, H. den Burger, H. Stoter, G. Brouwer, J. Nooter, K.
2001-01-01